Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1981 May;13(5):888–890. doi: 10.1128/jcm.13.5.888-890.1981

Choice and specificity of complement in complement fixation assay.

J Sethi, D Pei, Y Hirshaut
PMCID: PMC273911  PMID: 6787075

Abstract

This study examines the relative activity of various complement sources in a variety of antigen-antibody (Ag-Ab) complement fixation assay systems. Studied were Ag-Ab systems of cytomegalovirus, adenovirus, Pneumococcus, Coccidiodes, and guinea pig kidney. Ab titers in each system were determined by microcomplement fixation assay using two batches of titrated rabbit, monkey, cat, dog, human cord, human adult, and guinea pig sera as complement sources. Assay sensitivity and Ab titers proved to be strongly related to the complement sources. There was considerable variation in the ability of Ag-Ab complexes to bind the complement of each of the species tested. Guinea pig, rabbit, and monkey sera gave comparable titers in four of the five Ag-Ab systems tested. Cat serum complement was able to detect anti-adenovirus and anti-Pneumococcus reactivity only. Human adult, human cord, and dog sera exhibited anti-complementary activity. The study emphasizes the importance of complement source in determining both the specificity and sensitivity of complement fixation assays in a given Ag-Ab system.

Full text

PDF
888

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baumgarten A. Viral immunodiagnosis. Yale J Biol Med. 1980 Jan-Feb;53(1):71–83. [PMC free article] [PubMed] [Google Scholar]
  2. Colombani J., Colombani M., Dastot H., Elias A., Dausset J. Intérêt de l'utilisation du sérum humain comme source de complément dans une réaction de fixation du complément sur antigène plaquettaire. Nouv Rev Fr Hematol. 1968 Nov-Dec;8(6):864–868. [PubMed] [Google Scholar]
  3. Eilber F. R., Morton D. L. Demonstration in sarcoma patients of anti-tumor antibodies which fix only human complement. Nature. 1970 Mar 21;225(5238):1137–1138. doi: 10.1038/2251137a0. [DOI] [PubMed] [Google Scholar]
  4. Hirshaut Y., Pei D. T., Marcove R. C., Mukherji B., Spielvogel A. R., Essner E. Seroepidemiology of human sarcoma antigen (S1). N Engl J Med. 1974 Nov 21;291(21):1103–1107. doi: 10.1056/NEJM197411212912103. [DOI] [PubMed] [Google Scholar]
  5. Mukherji B., Hirshaut Y. Evidence for fetal antigen in human sarcoma. Science. 1973 Aug 3;181(4098):440–442. doi: 10.1126/science.181.4098.440. [DOI] [PubMed] [Google Scholar]
  6. Perryman L. E., Olsen R. G., Yohn D. S. Comparison of the serologic response in cats to various antigens, using homologous and heterologous complement. Am J Vet Res. 1973 Dec;34(12):1529–1532. [PubMed] [Google Scholar]
  7. SEVER J. L. Application of a microtechnique to viral serological investigations. J Immunol. 1962 Mar;88:320–329. [PubMed] [Google Scholar]
  8. Sethi J., Hirshaut Y. Complement-fixing antigen of human sarcomas. J Natl Cancer Inst. 1976 Sep;57(3):489–493. doi: 10.1093/jnci/57.3.489. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES